In a recent study, Cotter et al analyzed a cohort of HIV-infected pregnant women followed at a single site, to examine the risk of preterm delivery and other pregnancy outcomes. Their results indicated that combination therapy with protease inhibitors (PI), compared with monotherapy and combination therapy without PI, is indipendently associated with preterm delivery. We analyzed data from the largest surveillance study currently being conducted in Italy of the use of antiretroviral drugs in pregnancy, to establish the role of PIs in preterm delivery after controlling for important prognostic cofactors.
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infecfed pregnant women [1] / Ravizza, M.; Martinelli, P.; Bucceri, A.; Fiore, S.; Alberico., S; Tamburrini, E.; Tibaldi, C.; Guaraldi, Giovanni; Anzidei, G.; Maccabruni, A.; Crisalli, M. P.; Floridia, M.. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - STAMPA. - 195:6(2007), pp. 913-914. [10.1086/507045]
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infecfed pregnant women [1]
GUARALDI, Giovanni;
2007
Abstract
In a recent study, Cotter et al analyzed a cohort of HIV-infected pregnant women followed at a single site, to examine the risk of preterm delivery and other pregnancy outcomes. Their results indicated that combination therapy with protease inhibitors (PI), compared with monotherapy and combination therapy without PI, is indipendently associated with preterm delivery. We analyzed data from the largest surveillance study currently being conducted in Italy of the use of antiretroviral drugs in pregnancy, to establish the role of PIs in preterm delivery after controlling for important prognostic cofactors.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris